Literature DB >> 17848678

Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.

Marie-Pierre Vullierme1, Marie Giraud-Cohen, Pascal Hammel, Alain Sauvanet, Anne Couvelard, Dermot O'Toole, Philippe Levy, Philippe Ruszniewski, Valérie Vilgrain.   

Abstract

PURPOSE: To retrospectively evaluate computed tomographic (CT) findings in patients with in situ and invasive malignant intraductal papillary mucinous neoplasms (IPMNs) of the pancreas and to evaluate the accuracy for surgical resectability, with surgery and pathologic analysis as the reference standards.
MATERIALS AND METHODS: Institutional review board approval was obtained, and the informed consent requirement was waived. Forty-six patients with malignant IPMN proved at pathologic examination of the surgically resected specimen (n = 44) or laparotomy (n = 2) underwent surgery after multidetector CT was performed. CT findings were retrospectively evaluated to determine if a pancreatic malignant IPMN tumor was present; to make this determination, CT criteria were used to differentiate in situ from invasive tumors and signs of unresectability (liver metastasis, vascular CT pattern of encasement, or regional lymph node metastasis). The extent of the vascular CT pattern of encasement was recorded for each patient (no obliteration of the fat plane, obliteration of the fat plane of <50%, or obliteration of the fat plane of > or =50%). Statistical analysis was performed with the chi(2) and Student t tests.
RESULTS: CT revealed a mural nodule in the pancreatic duct wall in 14 patients with in situ carcinoma and one patient with invasive carcinoma (P < .003). CT revealed an infiltrative pancreatic mass in 17 patients with invasive carcinoma and two patients with in situ carcinoma (P < .02). Of the mural nodules, 93% were seen in patients with in situ carcinoma, whereas 90% of infiltrative pancreatic masses were observed in patients with invasive carcinomas. The positive predictive value of CT for determining resectability was 100%, and the overall accuracy of CT for determining resectability and unresectability was 74%. The positive predictive value of CT for determining unresectability was 17%, mainly owing to overestimation of arterial invasion.
CONCLUSION: CT is helpful in the differentiation of in situ and invasive IPMN. Classic vascular invasion criteria lead to the overestimation of surgical tumor unresectability in patients with malignant IPMN.

Entities:  

Mesh:

Year:  2007        PMID: 17848678     DOI: 10.1148/radiol.2451060951

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.

Authors:  Richard K G Do; Seth S Katz; Marc J Gollub; Jian Li; Jennifer LaFemina; Emily C Zabor; Chaya S Moskowitz; David S Klimstra; Peter J Allen
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

Review 3.  Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.

Authors:  S Nougaret; L Mannelli; M-A Pierredon; V Schembri; B Guiu
Journal:  Diagn Interv Imaging       Date:  2016-11-11       Impact factor: 4.026

Review 4.  Radiology of pancreatic neoplasms: An update.

Authors:  Luis Gijón de la Santa; José Antonio Pérez Retortillo; Ainhoa Camarero Miguel; Lea Marie Klein
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

5.  Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.

Authors:  Thula Cannon Walter; Ingo G Steffen; Lars H Stelter; Martin H Maurer; Marcus Bahra; Wladimir Faber; Fritz Klein; Hendrik Bläker; Bernd Hamm; Timm Denecke; Christian Grieser
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

6.  Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Ivan Pedrosa; Dennis Boparai
Journal:  World J Gastrointest Surg       Date:  2010-10-27

7.  Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation.

Authors:  Lucie Laurent; Marie-Pierre Vullierme; Vinciane Rebours; Frédérique Maire; Olivia Hentic; Claire Francoz; François Durand; Philippe Ruszniewski; Philippe Lévy
Journal:  United European Gastroenterol J       Date:  2016-08-16       Impact factor: 4.623

8.  Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography.

Authors:  Ling Tan; Ya-E Zhao; Deng-Bin Wang; Qing-Bing Wang; Jing Hu; Ke-Min Chen; Xia-Xing Deng
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

Review 9.  [Cystic tumors of the pancreas].

Authors:  H-J Brambs; M Juchems
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

10.  CT and MR imaging of multilocular acinar cell cystadenoma: comparison with branch duct intraductal papillary mucinous neoplasia (IPMNs).

Authors:  Christophe Delavaud; Gaspard d'Assignies; Jérome Cros; Philippe Ruszniewski; Pascal Hammel; Philippe Levy; Anne Couvelard; Alain Sauvanet; Safi Dokmak; Valérie Vilgrain; Marie-Pierre Vullierme
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.